news roundup
TrialScope, a company specializing in clinical trial transparency and compliance solutions, announced the launch of its Clinical Trial Transparency Service (CTTS) for sponsors. The new service hopes to improve patient engagement, lower costs, and increase transparency through a clinical trial publication website.
Advertisement
Neuropathic Pain Studies: Patient Selection, Study Design, and Clinical Trial Challenges
Tuesday, November 6, 2018 at 11am EST | 8am PST | 4pm GMT | 5pm CET Register Now |
GB Sciences, Inc. and Catalent Pharma Solutions announced that GB Sciences has selected Catalent to provide oral delivery systems, formulation development, and clinical-scale oral dose manufacturing of GB Sciences' proprietary active pharmaceutical ingredients for its Parkinson's disease therapies.
Advertisement
Identifying NASH Patients: Solutions and Strategies
Thursday, November 1, 2018, 11am EST Register Now |
Medidata announced that Decibel Therapeutics is adopting Medidata Cloud and specifically using its eTMF and eCOA/ePRO solutions. The agreement will support Decibel Therapeutics' clinical development for hearing loss, tinnitus, and balance disorders.
Advertisement
A Pan-cancer View of Immune Cell Activity, Immune Checkpoints, and Tumor Mutational Burden
Thursday, October 11, 2018 at 11am EDT
Register Now |
ActiGraph has announced the launch of its newest activity monitor, the CentrePoint Insight Watch. This watch hopes to deliver high quality, real-world data, and an enhance patient experiences during clinical drug trials and health research studies.
Advertisement
On the brink of change: How academic data and machine learning can revolutionize Alzheimer's drug development
On Demand
Learn More |
|
|